Keyword: Novasep

Research & Innovation

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

22.02.2023 -

Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.


Farmabios, Novasep and PharmaZell now Axplora

21.10.2022 -

Following the merger of French CDMO Novasep and German API maker PharmaZell in April this year, all brands of the two companies, including those of PharmaZell’s group...


Novasep‐PharmaZell Invests €7.3 Million in APIs

27.07.2022 -

Financed in part by the French government’s France Relance plan, Novasep‐PharmaZell is investing €7.3 million in production of active pharmaceuticals (APIs) at its...


Novasep and PharmaZell Conclude Merger

19.04.2022 -

Following exclusive negotiations that started last September, German API specialist PharmaZell and French CDMO Novasep have merged as of Apr. 7. The combined group will...


Novasep Invests in API Capabilities

21.12.2021 -

Novasep, a French CDMO, has announced a €6 million investment to increase and modernize manufacturing capabilities at its Chasse-sur-Rhône site to support new generation...


Novasep and McSAF in ADC Partnership

26.11.2021 -

French CDMO Novasep is collaborating with compatriot biotech McSAF on the preclinical production of Adcitmer, a next-generation antibody drug conjugate (ADC) for treating...


Avid Bioservices Expanding Cell and Gene Therapy

25.10.2021 -

Avid Bioservices, a biologics-oriented CDMO based in the US state of California, is building a new plant in Costa Mesa, California, as part of a plan to expand its cell...


Pharmazell and Novasep in Exclusive Merger Talks

23.09.2021 -

German API specialist PharmaZell and French CDMO Novasep are in exclusive talks about a merger that the companies say would create a leading European platform in the...